154 related articles for article (PubMed ID: 10867208)
1. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?
Farkas E; De Vos RA; Jansen Steur EN; Luiten PG
Neurobiol Aging; 2000; 21(2):235-43. PubMed ID: 10867208
[TBL] [Abstract][Full Text] [Related]
2. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?
Farkas E; De Jong GI; Apró E; De Vos RA; Steur EN; Luiten PG
Ann N Y Acad Sci; 2000 Apr; 903():72-82. PubMed ID: 10818491
[TBL] [Abstract][Full Text] [Related]
3. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease.
Kitaguchi H; Ihara M; Saiki H; Takahashi R; Tomimoto H
Neurosci Lett; 2007 May; 417(2):128-31. PubMed ID: 17403574
[TBL] [Abstract][Full Text] [Related]
4. Review: cerebral microvascular pathology in ageing and neurodegeneration.
Brown WR; Thore CR
Neuropathol Appl Neurobiol; 2011 Feb; 37(1):56-74. PubMed ID: 20946471
[TBL] [Abstract][Full Text] [Related]
5. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
de la Torre JC
J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
[TBL] [Abstract][Full Text] [Related]
6. Cerebral microvascular pathology in aging and Alzheimer's disease.
Farkas E; Luiten PG
Prog Neurobiol; 2001 Aug; 64(6):575-611. PubMed ID: 11311463
[TBL] [Abstract][Full Text] [Related]
7. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
de la Torre J
J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
[TBL] [Abstract][Full Text] [Related]
8. Vascular risk factors: a ticking time bomb to Alzheimer's disease.
de la Torre JC
Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):551-9. PubMed ID: 23813612
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.
Schreiber SJ; Doepp F; Spruth E; Kopp UA; Valdueza JM
J Neurol; 2005 Oct; 252(10):1171-7. PubMed ID: 16151603
[TBL] [Abstract][Full Text] [Related]
10. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.
Farkas E; De Jong GI; de Vos RA; Jansen Steur EN; Luiten PG
Acta Neuropathol; 2000 Oct; 100(4):395-402. PubMed ID: 10985698
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
12. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights.
Mazza M; Marano G; Traversi G; Bria P; Mazza S
J Alzheimers Dis; 2011; 23(3):375-89. PubMed ID: 21098977
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.
Kalaria RN
Ann N Y Acad Sci; 1999; 893():113-25. PubMed ID: 10672233
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies.
De Jong GI; De Vos RA; Steur EN; Luiten PG
Ann N Y Acad Sci; 1997 Sep; 826():56-74. PubMed ID: 9329681
[TBL] [Abstract][Full Text] [Related]
15. Vascular basis of Alzheimer's pathogenesis.
de la Torre JC
Ann N Y Acad Sci; 2002 Nov; 977():196-215. PubMed ID: 12480752
[TBL] [Abstract][Full Text] [Related]
16. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
17. Cerebral angiography, blood flow and vascular reactivity in progressive hypertension.
Li Y; Shen Q; Huang S; Li W; Muir ER; Long JA; Duong TQ
Neuroimage; 2015 May; 111():329-37. PubMed ID: 25731987
[TBL] [Abstract][Full Text] [Related]
18. Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.
Kitagawa K
J Alzheimers Dis; 2010; 20(3):855-9. PubMed ID: 20182039
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
de la Torre JC
Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
[TBL] [Abstract][Full Text] [Related]
20. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?
de la Torre JC
Ann N Y Acad Sci; 2000 Apr; 903():424-36. PubMed ID: 10818533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
